Back to Search Start Over

Anabolic androgenic steroid dependence is associated with impaired emotion recognition.

Authors :
Hauger LE
Sagoe D
Vaskinn A
Arnevik EA
Leknes S
Jørstad ML
Bjørnebekk A
Source :
Psychopharmacology [Psychopharmacology (Berl)] 2019 Sep; Vol. 236 (9), pp. 2667-2676. Date of Electronic Publication: 2019 Apr 02.
Publication Year :
2019

Abstract

Rationale: Illicit use of anabolic androgenic steroids (AAS) has grown into a serious public health concern throughout the Western World. AAS use is associated with adverse medical, psychological, and social consequences. Around 30% of AAS users develop a dependence syndrome with sustained use despite adverse side effects. AAS dependence is associated with a high frequency of intra- and interpersonal problems, and it is central to identify factors related to the development and maintenance of dependence.<br />Methods: The present study investigated the ability to recognize emotion from biological motion. The emotional biological motion task was administered to male AAS dependent users (AAS dependents; n = 45), AAS non-dependent users (AAS non-dependents; n = 38) and a comparison-group of non-using weightlifters (non-users; n = 69).<br />Results: Multivariate analysis of variance showed a general impairment in emotion recognition in AAS dependents, compared to the non-using weightlifters, whereas no significant impairment was observed in AAS non-dependents. Furthermore, AAS dependents showed impaired recognition of fearful stimuli compared to both AAS non-dependents and non-using weightlifters. The between-group effect remained significant after controlling for Intelligence Quotient (IQ), past 6 months of non-AAS drug use, antisocial personality problems, anxiety, and depression.<br />Conclusion: AAS dependents show impaired emotion recognition from body movement, fear in particular, which could potentially contribute to higher frequency of interpersonal problems and antisocial behaviors in this population.

Details

Language :
English
ISSN :
1432-2072
Volume :
236
Issue :
9
Database :
MEDLINE
Journal :
Psychopharmacology
Publication Type :
Academic Journal
Accession number :
30941469
Full Text :
https://doi.org/10.1007/s00213-019-05239-7